STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Neuronetics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.91+0.02 (+1.33%)
Close on Oct 19, 2026
- Market cap
- $139.68M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.78 (−29.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Neuronetics, Inc. grew revenue 39.6% to $155.10M over the twelve months to Jun 30, 2026. Free cash flow was -$11.28M.
Revenue
$155.10M
+39.6% vs. a year earlier
Operating income
-$22.86M
TTM Q2 2026
Free cash flow
-$11.28M
TTM Q2 2026
EPS, diluted
-$0.44
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $139.68M
- P/E ratio
- –
- Price to sales
- 0.90
- Price to book
- 7.83
- Dividend yield
- –
- Free cash flow yield
- -8.07%
Fundamentals
- Revenue
- $155.10M
- Net income
- -$30.43M
- EPS, diluted
- -$0.44
- Free cash flow
- -$11.28M
- Book value per share
- $0.24
- Diluted shares
- 73M
Eleven years at a glance
Fiscal years 2015 to 2025 and trailing twelve months, USD
Revenue
$155.10M+39.6% YoY
Gross profit
$76.19M+22.1% YoY
Operating income
-$22.86M
Net income
-$30.43M
EPS, diluted
-$0.44
Free cash flow
-$11.28M
Reported periodTrailing twelve months